Antibody–Drug Conjugates: Clinical Perspectives from Europe

Dr. Daniel Morgensztern, Section Editor of Chest and Lung Disease for the journal Cancer, is joined by Dr. Emiliano Calvo and Dr. André Mansinho to discuss a new supplement in Cancer focused on recent advances in antibody–drug conjugates (ADCs). Their conversation covers the main mechanisms of resistance and action, key considerations for oncologists related to toxicities, and the evolving outlook for ADCs, including next-generation strategies and their role in clinical practice. Read the supplement in Cancer: https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2026/132/S1 Follow Cancer on social media: x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals Original music by J.Gilman